Research News - December 16, 2016

If you travel for hospital business, consider enrolling in Partners TravelSafe, a travel information and emergency assistance program for employees of Massachusetts General Hospital and other Partners HealthCare hospitals. TravelSafe offers travel information, active alerts, emergency assistance and a single point of contact should you encounter trouble while traveling domestically or internationally. TravelSafe’s global hotline is +1 443-965-9242.

When you book travel through one of Partners’ approved travel agencies, Great GetAways or Egencia, your travel details are automatically registered with TravelSafe. You also have the option to manually enter your trip details into the TravelSafe site: www.partners.org/travelsafe. The site also provides more information about the program.  Questions can be sent to travelsafe@partners.org

Please click here to read the latest news from the Patient-Centered Outcomes Research Institute.

Please click here to read the latest news from the NIH Office of Extramural Research.

Monday, December 19, 2016, 4:00 – 5:00 PM, CNY 149, Isselbacher Auditorium, 7th floor

“The sensory neurons of touch”
David D. Ginty, Ph.D.
Edward R. and Anne G. Lefler Professor of Neurobiology, Harvard Medical School
Investigator, Howard Hughes Medical Institute

Shuttle bus leaves MGH Main Campus (Blossom St.) every 15 minutes.

Deadline: Tuesday, December 20th, 5pm EST

The Center for Skeletal Research (CSR), based in the Endocrine Unit at MGH, and funded by the National Institute of Arthritis and Musculoskeletal Diseases (NIAMS) is announcing a request for Pilot and Feasibility Research proposals. ONE clinical grant ($30,000/year) will be awarded this year, which may be renewable for an additional year for a maximum of two years funding in total. Awardees will be expected to present progress to CFSR members biannually and provide a written annual report.

Eligibility is based on the criteria listed below:

1. Junior faculty proposing highly focused Skeletal Biology research projects with the goal of generating preliminary data sufficient to support an application for independent NIH research support. Applicants in this group must meet the NIH Early Investigator Criteria (New Investigators who have had less than 10 years of research or research training experience after the completion of their terminal research degree or medical residency, see http://grants.nih.gov/grants/new_investigators/index.htm).  Awardees of K grants in their last 2 years of K funding may apply with committed effort but cannot receive salary from the P&F.
2. Established researchers from outside the bone field proposing innovative studies relevant to Skeletal Biology.
3. Established Skeletal Biology investigators proposing studies relevant to Skeletal Biology that represents a clear departure from their established line of investigation. Investigators must invest at least 1 calendar month of effort.  If salary requests do not reflect this effort, cost-sharing plans must be indicated. Applicants who are not U.S. citizens or permanent U.S. residents must have active visas permitting them to remain in the U.S. for the full period of the proposed research Funding is anticipated to start on June 1, 2017.

For submission details, go to https://csr.mgh.harvard.edu/pilot-and-feasibility-studies

Please click here to review the recent program announcements from the Congressionally Directed Medical Research Programs (CDMRP).

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org.  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

• Name of the Principal Investigator with appropriate contact information
• A descriptive title of the potential application
• Brief description of the project
• Brief description of why you specifically should be selected to receive institutional nomination for this award

If there is more than one MGH investigator interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities
Please click here for more information and for our internal deadlines.

• St. Baldrick’s Foundation
• T Cell Reagent Research for the Study of Allergic Diseases (U19)
• Asthma and Allergic Diseases Cooperative Research Centers (U19)

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please contact Erin McGivney at 617-643-6471.

Please note that any grant that brings in less than 15% in indirect costs (IDC) will need to be supplemented up to the 15% equivalent by existing investigator or departmental sundry funds. Resolution of this issue must occur prior to submission of the award.

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these funding opportunities.  Note that proposals are still routed through the standard InfoEd/Research Management process.

• Bridge to Success Award for Early Career Investigators, American Academy of Sleep Medicine (AASM)/American Sleep Medicine Foundation (ASMF)
• Research Professor Grants, American Cancer Society (ACS)
• AHA Institutional Research Enhancement Award (AIREA), American Heart Association (AHA)
• Gene Therapy to Cure HIV, amfAR, The Foundation for AIDS Research
• Innovation in Regulatory Science Awards (IRSA), Burroughs Wellcome Fund (BWF)
• New Investigator Fellowship Training Initiative (NIFTI), Foundation for Physical Therapy (FPT)
• Bronya J. Keats Award for International Collaboration in Research on FA, Friedreich's Ataxia Research Alliance (FARA)
• General Research Grant, Friedreich's Ataxia Research Alliance (FARA)
• Kyle Bryant Translational Research Award, Friedreich's Ataxia Research Alliance (FARA)
• HIVMA Clinical Fellowship, Infectious Diseases Society of America (IDSA)/HIV Medicine Association (HIVMA)
• Research Grants, Pediatric Low Grade Astrocytoma Foundation (PLGA)
• SPARK Clinical Site Network Request for Applications (RFA), Simons Foundation/Simons Foundation Autism Research Initiative (SFARI)
• Wireless Innovation Project, Vodafone Americas Foundation

Please click here for further details on these funding opportunities.

For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link: http://grants.nih.gov/grants/guide/WeeklyIndex.cfm

The Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine
Application Deadline: January 4, 2017

MGH ECOR Formulaic Bridge Funding Support
Application Deadline: January 7, 2017; 7th day of each month

Merck KGaA Darmstadt Germany Biopharma Innovation Cup 2017
Application Deadline: January 31, 2017

Boston Biomedical Innovation Center (B-BIC) Accepting PILOT & DRIVE Grant Pre-Proposals

Clinical Research Billing from Study Start to Completion - January 22, 2017

Basic Biostatistics for Clinical Research - Thursdays, January 5, 12, 19, 26, February 2, 2017

Conquering the K: Applying for an NIH Career Development Award - Weekly, February 1 - March 21

Looking for something you saw in a previous Research News release? Check out our archive!